Tetraphase Pharmaceuticals, Inc (NASDAQ:TTPH) Experiences Heavier than Average Trading Volume

The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. The firm has “Buy” rating by Pivotal Research given on Monday, July 24. The firm earned “Buy” rating on Thursday, January 14 by Deutsche Bank. The firm has “Buy” rating by Pivotal Research given on Thursday, October 20. As per Thursday, November 19, the company rating was upgraded by SunTrust. Jpmorgan Chase & Co, a New York-based fund reported 4,329 shares. The stock of SUPERVALU INC. Therefore 38% are positive. Remember a SMA (simple moving average) will smooth out all the data and make it equal but the Tenkan Line will take the highest high and lowest low over the last 9 periods. Stifel Nicolaus has “Buy” rating and $15 target. HC Wainwright initiated coverage on Tetraphase Pharmaceuticals in a research report on Tuesday, July 11th. On Wednesday, September 9 the stock rating was downgraded by Nomura to “Neutral”.

09/09/2015 – Tetraphase Pharmaceuticals, Inc. was downgraded to “neutral” by analysts at Robert W. Baird. The firm has “Outperform” rating given on Friday, May 13 by Wedbush. Zacks Investment Research lowered Tetraphase Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Wednesday, May 10th. The company has an average rating of Buy and a consensus target price of $10.65. BMO Capital Markets reiterated a “buy” rating and set a $12.00 target price on shares of Tetraphase Pharmaceuticals in a research note on Friday, May 5th. RBC Capital Markets has “Outperform” rating and $64 target.

09/09/2015 – Tetraphase Pharmaceuticals, Inc. was downgraded to “hold” by analysts at Cantor Fitzgerald. Investors looking for growth stocks may be willing to shell out a little more for a stock that has the possibility of increasing EPS at a quicker pace. During the same quarter in the prior year, the firm earned ($0.47) EPS. The stock was sold at an average price of $5.86, for a total value of $41,928.30. 403.62 million shares or 2.20% more from 394.94 million shares in 2016Q3 were reported. Canada Pension Plan Investment Board holds 36,600 shares. 154 are owned by Parkside State Bank And. Commonwealth Equity Services stated it has 21,294 shares or 0% of all its holdings. Louisiana State Employees Retirement Systems reported 0.03% of its portfolio in SUPERVALU INC. Guggenheim Ltd accumulated 0.1% or 788,164 shares. Alliancebernstein Ltd Partnership has invested 0% in SUPERVALU INC. (NYSE:SVU). Northwestern Mutual Wealth Com reported 1,609 shares or 0% of all its holdings. Henderson Group Inc Public Limited Co stated it has 0.02% of its portfolio in Devon Energy Corp (NYSE:DVN). Sumitomo Mitsui Trust Incorporated has invested 0.12% in Devon Energy Corp (NYSE:DVN). Cipher Capital L P holds 0.45% of its portfolio in SUPERVALU INC. The company has market cap of $52.12 billion. The Company’s divisions include Wholesale and Retail. It has a 6.11 P/E ratio. About shares traded. Highpower International Inc (HPJ) has risen 140.54% since August 28, 2016 and is uptrending. Devon Energy Corp (NYSE:DVN) has risen 13.24% since August 28, 2016 and is uptrending. It has underperformed by 7.20% the S&P500. The company had revenue of $1.59 million for the quarter, compared to analyst estimates of $1.54 million. Wade G W & Inc. bought a new position in shares of Tetraphase Pharmaceuticals during the first quarter worth approximately $138,000.

Investors sentiment decreased to 1.31 in 2016 Q4. Its down 0.16, from 1.47 in 2016Q3. Shares of Tetraphase Pharmaceuticals, Inc. 72 funds opened positions while 223 raised stakes. Blackrock Fund holds 1.22M shares. (NASDAQ:TTPH) from a sell rating to a hold rating in a report released on Tuesday morning. Conducting thorough fundamental research on stocks even after they have broken out may help the investor understand the reason behind the move, and whether it is likely to continue or if it is just a temporary spike. It seems that Tetraphase Pharmaceuticals, Inc. Tiaa Cref Inv Management Lc owns 127,172 shares for 0% of their portfolio. Goldman Sachs Group Inc Incorporated reported 31,595 shares. Tetraphase Pharmaceuticals, is based in Watertown, Massachusetts. Cibc Markets Corporation reported 35,888 shares stake. 698,000 are held by Rock Springs Mgmt Limited Partnership.

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) is another stock that is grabbing investors attention these days.

Tetraphase Pharmaceuticals has a 52 week low of $3.11 and a 52 week high of $9.93 The company’s market cap is now $0. The Firm uses its chemistry technology to create antibiotics for multidrug-resistant infections. It now has negative earnings. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug resistant Gram-negative infections. the firms product under development includes eravacycline oral formulation, TP-834 and TP-271.

Since March 15, 2017, it had 1 buying transaction, and 0 selling transactions for $82,370 activity.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *